Applied therapeutics announces presentation of pre-clinical data on at-001 for the treatment of diabetic cardiomyopathy at the american heart association (aha) scientific sessions 2020

Treatment with at-001 normalizes cardiac energetics and improves cardiac function in a mouse model of diabetic cardiomyopathy (dbcm) treatment with at-001 normalizes cardiac energetics and improves cardiac function in a mouse model of diabetic cardiomyopathy (dbcm)
APLT Ratings Summary
APLT Quant Ranking